We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Samsung

Develops, manufactures, and markets diagnostic products and solutions for IVD and point-of-care applications read more Featured Products: More products

Download Mobile App




Samsung Extends its Medical Device Business in the European Market

By Nadia Liefsoens, MedImaging Regional Director
Posted on 18 Mar 2013
Print article
A new medical device brand, called Geo, is showing a company’s commitment to global health through innovative medical devices. The Geo brand includes XGeo for digital radiography, UGeo for ultrasound diagnostic systems, and LabGeo for in vitro diagnostics.

Samsung Electronics Co., Ltd. (Suwon, South Korea) launched its medical brand Geo with Samsung Medison (Gangwon, South Korea) at the European Congress of Radiology (ECR) 2013, held in Vienna (Austria) during March 7-11, 2013. Samsung also presented its latest medical equipment and technologies with Samsung Medison.

“Samsung is committed to bringing a new wave of innovation to the radiology market in Europe with our newly established medical equipment brand,” said S. I. Cho, president and head of the health and medical equipment business at Samsung Electronics and CEO of Samsung Medison. “Samsung will continue to develop products that offer fast, accurate diagnosis to both doctors and patients.

Samsung Electronics’ digital radiography (DR) range provides high performance through panel detectors. Even with dose reduction, XGEeo GC80 still provides effective images and diagnosis, which are both critical for the health and safety of patients. The DR’s soft-handling technology allows users to move the device with low physical pressure even without a side-handle.

The upgraded Accuvix A30 ultrasound system features the single crystal transducer optimized for radiology. The single crystal probe (transducer) provides a wide bandwidth, which allows the user to utilize a wider range of frequencies, granting a better resolution and penetration. Furthermore, for the first time, Samsung Electronics presented portable computed tomography (CT) products from NeuroLogica (Danvers, MA, USA). The company was acquired by Samsung Electronics earlier in 2013.

Moreover, Samsung hosted a satellite symposium at the Congress regarding a new tool for detecting and diagnosing breast cancer, the ultrasound ElastoScan. Speakers discussed the technology within ElastoScan and its diagnostic capability to help detect breast cancer at an early stage and support surgery procedure.

Samsung Electronics Co., Ltd. is a global leader in technology. Samsung Medison is a leading global medical devices company. Founded in 1985, the company markets innovative medical devices including diagnostic ultrasound, digital X-ray, and blood analyzers, in 110 countries worldwide. The company has attracted global attention in the medical field with its R&D capabilities and advanced technologies. In 2011, Samsung Medison became an affiliate company of Samsung Electronics, integrating information technology (IT), image processing, semiconductor and communication technologies into medical devices.

Related Links:

Samsung Electronics
Samsung Medison




New
Needle Guide Disposable Kit
Verza
Ultrasound Table
Women’s Ultrasound EA Table
X-ray Diagnostic System
FDX Visionary-A
Ultrasound Imaging System
P12 Elite

Print article

Channels

Radiography

view channel
Image: AI can identify “mammographically-visible” types of interval cancers earlier by flagging them at the time of screening (Photo courtesy of ScreenPoint Medical)

AI Improves Early Detection of Interval Breast Cancers

Interval breast cancers, which occur between routine screenings, are easier to treat when detected earlier. Early detection can reduce the need for aggressive treatments and improve the chances of better outcomes.... Read more

Nuclear Medicine

view channel
Image: In vivo imaging of U-87 MG xenograft model with varying mass doses of 89Zr-labeled KLG-3 or isotype control (Photo courtesy of L Gajecki et al.; doi.org/10.2967/jnumed.124.268762)

Novel Radiolabeled Antibody Improves Diagnosis and Treatment of Solid Tumors

Interleukin-13 receptor α-2 (IL13Rα2) is a cell surface receptor commonly found in solid tumors such as glioblastoma, melanoma, and breast cancer. It is minimally expressed in normal tissues, making it... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.